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Negative symptoms have emerged as a replicable factor of symptomatology 
within schizophrenia. Although rating scales provide assessments along dimensions 
of severity, categorization of a negative symptom subtype is typically concluded. 
Despite an accumulation of findings that support categorical conceptualization, the 
data are also consistent with a dimensional-only model where negative symptom 
subtypologies simply reflect an extreme on a continuum of severity. Previous studies 
(Blanchard, et al, 2005) have used taxometric statistical methods to confirm the 
existence of a negative symptom subtype; however, the nature of taxometric methods 
requires replication (Waller & Meehl, 1998). The current investigation is a taxometric 
analysis of the World Health Organization Ten-Country Study of Schizophrenia. Data 
from a subset of 694 individuals were analyzed using the taxometric methods of 
maximum covariance analysis (MAXCOV) and mean above minus below a cut 
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Chapter 1: Introduction  
Schizophrenia is a serious mental illness that affects people world wide. It is 
recognized in every culture with an estimated prevalence rate of between 1.4 and 1.6 
per 1000 people (Jablensky, 2000). The diagnostic criteria for schizophrenia include 
delusions, hallucinations, disorganized speech, grossly disorganized or catatonic 
behavior, and negative symptoms (including flattened affect, apathy, and reduced 
speech output; American Psychiatric Association, 2000). Schizophrenia is associated 
with profound functional impairment, including joblessness (for a comprehensive 
review, see Marwaha & Johnson, 2004) and homelessness (for a review, see Folsom 
& Jeste, 2002). The estimated annual cost of the illness in the United States has been 
estimated at $32.5 billion (Rice & Miller, 1998). These costs are comparable to the 
annual costs of depression-a far more prevalent illness (Hu, 2006). 
Despite many years of intensive study, the causes of schizophrenia remain a 
mystery. One of the single biggest reasons for this failing is the heterogeneous nature 
of the illness. The presentation of schizophrenia can vary widely between patients. 
One patient can present with flagrant hallucinations and delusions, while another can 
appear with disorganized speech and inappropriate affect. Yet both of these 
individuals will receive a diagnosis of schizophrenia. 
The subtypes of schizophrenia recognized by the American Psychiatric 
Association are an attempt at reducing this heterogeneity, by grouping patients based 
on similar characteristics (i.e. – paranoid delusions, disorganized thinking, and 
catatonic behavior; [American Psychiatric Association, 2000]). However, these 




1991) which has reduced their utility in this regard. The consequences of this 
heterogeneity are not trivial and have lead directly to a poor understanding of the 
genetic etiology of the illness. 
Despite the high heritability of schizophrenia (Owen, O’Donovan, Gottesman, 
2002) scientists have been unable to determine the genetic underpinnings of the 
illness (DeLisi, 1997). Jablensky (2006) notes that genetic heterogeneity (one illness 
caused by multiple genes) is a common cause for human illnesses. Further, he argues 
that other disciplines have had success in resolving genetic heterogeneity by dividing 
diverse illnesses into subtypes; something that schizophrenia researchers have 
attempted, but never satisfactorily resolved. In order to make substantive progress in 
understanding schizophrenia, valid subtypes must be identified. Persons (1987) has 
argued that the best way to delimit phenotypic heterogeneity is to divide the patient 
population based on a characteristic of interest so that patients with the symptom can 
be compared to patients without the symptom. This allows for a within-group 
comparison that controls for several variables that have a likely impact on results 
(such as a history of inpatient hospitalization and use of antipsychotic medications). 
Consistent with this approach, some have argued for the utility of negative symptoms 
as a valid subtype within schizophrenia (Buchanan & Carpenter, 1994) as these 
symptoms have important implications for the course of the illness (Kirkpatrick, 
Buchanan, Ross, & Carpenter, 2001) and show greater temporal stability than the 




Chapter 2: Negative Symptoms in Schizophrenia 
Section 1: The Concept of Negative Symptoms in Schizophrenia 
The symptoms of schizophrenia have been bifurcated into positive and 
negative symptoms. Positive symptoms are the most clearly recognized symptoms of 
schizophrenia and include hallucinations and delusions. Positive symptoms are often 
thought of as a release of higher order cognitive controls (Hughlings-Jackson, 1931). 
Negative symptoms, on the other hand, represent a deficit of normal functioning 
(Hughlings-Jackson, 1931). Typically, the symptoms that are recognized in this 
category include diminished emotional expression (flat affect), poverty of speech, 
lack of pleasure from social or physical stimuli (anhedonia), lack of drive (avolition), 
and apathy (McGlashan and Fenton, 1992). The consensus on this list of symptoms 
was hampered, in part, by a lack of reliable assessments for certain types of negative 
symptoms (Johnstone, 1989). However, with the introduction of measures such as 
Andreason’s Scale for the Assessment of Negative Symptoms (SANS; Andreason, 
1983), the validity of negative symptoms could be confirmed. Once accurate 
measurement tools were available, theories about the structure and causes of negative 
symptoms in schizophrenia began to develop rapidly. Two such theories of historical 
significance are Andreason’s theory of positive and negative schizophrenia (1982) 
and Crow’s theory of type I and type II schizophrenia (1980).  
Andreason’s early theory of positive and negative schizophrenia divided 
patients into three groups: positive, negative, and mixed. Patients with predominantly 
positive symptoms are categorized as having “positive schizophrenia.” Similarly, 




schizophrenia.” Patients that fit into both of these categories were diagnosed with 
mixed schizophrenia. Dividing patients into these groups yielded differences in 
various domains of functioning (Andreason & Olsen, 1982). Patients classified as 
having negative schizophrenia tended to have a longer length of hospitalization, have 
a lower score on the Mini Mental Examination, and a larger ventricle to brain ration 
(indicating general brain deterioration). (Although caution must be used with this last 
finding as it was not replicated in a later study (Andreason, Flaum, Swayze, Tyrell, & 
Arndt, 1990)). 
While Andreason’s theory proved to be a useful early conceptualization of 
negative symptoms, a fundamental flaw quickly emerged. The mixed schizophrenia 
group was so large that the utility of this system came into serious question. What’s 
more, the temporal stability of the system was low as patients often switched between 
diagnostic groups (Andreason, et al., 1994). Although this early approach to 
categorizing positive and negative symptoms has been largely abandoned, the 
introduction of the SANS and SAPS scales has helped to move the field forward and 
led to further developments in the understanding of the structure of schizophrenic 
symptomatology. 
Instead of merely describing the structure of negative symptoms, Crow (1980) 
suggested that positive and negative symptoms arose from different underlying 
neuropathologies. While maintaining that the fundamental liability for schizophrenia 
was the same across all subtypes (Crow, 1985), he believed that negative symptoms 
primarily arose from structural changes (arising from cell death) in the brain. These 




symptoms, however, resulted from an increase in dopamine receptors, a claim 
supported by the effectiveness of antipsychotic medications in their treatment. 
Negative symptoms do not respond to these medications because antipsychotics do 
not affect their underlying cause. Because these two sets of symptoms are 
independent of one another, it is possible for them to co-occur. 
Section 2: The Structure of Negative Symptoms in Schizophrenia  
While these theories can be tested empirically, their development was based 
on clinical judgment and not necessarily on the empirically-determined structure of 
schizophrenic symptomatology. This complaint has also been made of the DSM (for a 
discussion see chapter two of Schmidt, Kotov, and Joiner, 2004). One of the tools for 
the statistical investigation of the relationship between positive and negative 
symptoms is factor analysis. If positive and negative factors emerge as separate 
factors, this bolsters the claim that these symptoms are, in fact independent; this then 
provides an indication that negative symptoms are not merely secondary to other 
symptoms. 
In the factor analytic studies that have been conducted on the symptoms of 
schizophrenia, there is often great disagreement on the number of factors identified. 
Some of the first studies on the nature of schizophrenic symptoms found there to be 
two factors: positive and negative symptoms (Lewine, Fogg, & Meltzer, 1983; Kay, 
Opler, & Fiszbein, 1986). Subsequent models have identified three factors: positive, 
negative, and disorganized (which typically encompasses symptoms of formal 
thought disorder and bizarre behavior) (Palacios-Arus, Herran, Sandoya, Gonzalez de 
la Huebra, & Diez-Manrique, 1995; Grube, Bilder, & Goldman, 1998). Others have 




factor models encompassing positive, negative, relational or emotional disorder, 
disorganized, and excitement symptoms (Nakaya, Suwa, & Ohmori, 1999). However, 
as pointed out by Blanchard and Cohen (2006), while the number of factors does 
vary, negative symptoms consistently emerge as a separate factor. Thus, the results of 
factor analytic studies consistently indicate that negative symptoms represent a 
dimension that is separate from psychotic and affective symptoms and not merely 
secondary to them. 
Given the above findings, the question then becomes whether individual 
differences in negative symptoms lie along a continuum or whether individual 
differences are best represented as categorical distinctions. Several theories have been 
outlined to describe categorical difference in the negative symptoms of schizophrenia; 
foremost among them is the deficit syndrome. This concept was introduced in 1988 
by Carpenter, Heinrichs, and Wagman. Patients with the deficit syndrome are 
characterized as having “primary and enduring” negative symptoms. The distinction 
between primary and secondary symptoms (which was previously discussed) is made 
based on whether the negative symptoms are endogenous to the illness (primary) or 
due to some external factor: such as medication, depression, or neurocognitive 
dysfunction (secondary). The “enduring” requirement (12 months and/or present 
during periods of stability) is made to ensure that the symptoms designated as 
primary truly represent endogenous features. If a symptom persists over time, then the 
clinician can be reasonably assured that this symptom is, in fact, not due to secondary 
source. Symptoms sufficient for a diagnosis of the deficit syndrome include restricted 




diminished sense of purpose, and diminished social drive (Kirkpatrick, Buchanan, 
McKenney, Alphs, & Carpenter, 1980). Several lines of evidence exist to support the 
categorical model of negative symptoms. Specifically, negative symptoms have been 
found to be informative in regards to course, prognosis, and other aspects of the 
schizophrenia illness. 
Section 3: Course and Symptom Correlates 
Several different important outcomes have been found to be associated with 
negative symptoms. One clinically relevant correlate of negative symptoms is the 
patient’s current level of functioning. In a study of seven measures of negative 
symptoms, Fenton and McGlashan (1992) found that all of these measures yielded 
findings indicating that the more severe the patient’s negative symptomatology the 
worse the long-term outcome. However, as pointed out by Palacios-Arus, et al. 
(1995), care must be taken because one of the most commonly used measures of 
negative symptoms (the SANS) may share item content with certain outcome 
measures. However, when item content is controlled, there remain many studies that 
find correlations between negative symptoms and functional outcome measures. 
Several such studies have found that patients with pronounced negative symptoms 
have a reduced ability to care for themselves and live independently once released 
from the hospital (Dickerson, Ringel, & Parente, 1999; Moller, Bottlender, Wegner, 
Wittmann, & Straub, 2000). In addition, ability to work (specifically competence, 
ability to be supervised, and motivation to work) has also been found to be impaired 
in these patients (Suslow, Schonauer, Ohrmann, Eikelmann, & Reker, 2000). 




(Horan & Blanchard, 2003; Blanchard, Horan, & Collins, 2005; Milev, Ho, Arndt, & 
Andreason, 2005). 
While impairment from negative symptoms is apparent after the onset of 
illness, other results suggest that this impairment is a part of a more enduring profile 
of the illness. Premorbid adjustment has been found to be worse in patients with 
elevated negative symptoms (McGlashan & Fenton, 1992; for a review, see Walker 
and Lewine, 1988). Studies have found that negative symptoms identified after the 
onset of the illness are associated with a premorbid pattern of gradual withdrawal 
from interests and peer relationships (Garver, Nair, & Christensen, 1991) which is 
evident in early childhood (Horan & Blanchard, 2003; Buchanan, Kirkpatrick, 
Heinrichs, & Carpenter, 1990). Such a history of impairment is indicative of an 
insidious onset and is evidence that negative symptoms are enduring characteristics of 
the illness (Andreason, Flaum, Swayze, Tyrell, & Arndt, 1990). 
Given the clinical significance of negative symptoms, the concern then 
becomes how best to treat these symptoms. Current antipsychotics are largely 
ineffective in treating negative symptoms (Buchanan, Breier, Kirkpatrick, Ball, & 
Carpenter, 1998; Malaspina, Goetz, Yale, Berman, Friedman, Tremeau, et al, 2000; 
Filbey, Holcomb, Nair, Christensen, & Garver, 1999). Studies that report 
improvement in negative symptoms typically find that there are improvements in 
secondary negative symptoms (symptoms that are not endogenous to the illness but 
are instead due to other factors such as drugs, psychosis, or depression) but the core 
set of negative symptoms remain unaffected (Garver, Holcomb, & Christensen, 




culminated in a call to action by the NIMH, FDA, and the drug industry. In 2006, an 
NIMH consensus workshop was held to examine the problem of enduring negative 
symptoms (Kirkpatrick, Fenton, Carpenter, & Marder, 2006). Experts at this meeting 
concluded that negative symptoms represent a currently unmet therapeutic need and 
that further study into the nature of negative symptoms and a continued search for 
potential treatments represent important goals for the scientific community. 
The fact that antipsychotics are ineffective in treating negative symptoms 
gives evidence to theories such as Crow’s (1980, 1985) which state that positive and 
negative symptoms arise from different biological processes. Because negative 
symptoms are not responsive to medication that is effective in treating positive 
symptoms, it is likely that they are arising from different underlying neurotransmitter 
processes. As shown below, further evidence for separate pathophysiological 
pathways can be found in neurocognitive functioning, differences in eyetracking 
patterns, and in genetic liability to the disease. 
Neurocognitive functioning is considered to be generally impaired amongst 
people with schizophrenia (for a review, see Bowie & Harvey, 2005). However, 
studies have shown that these cognitive deficits are more profound among patients 
with elevated negative symptoms (Buchanan, Strauss, Kirkpatrick, Holstein, Breier, 
& Carpenter, 1994). Studies have found that negative symptoms are correlated with 
worse performance on measures of frontal lobe functioning (Horan & Blanchard, 
2003; Brazo, Delamillieure, Morello, Halbecq, Marie, & Dollfus, 2005), sensory 
integration (Arango, Kirkpatrick, & Buchanan, 2000), and attention (Buchanan, 




deficits continues to be evident in elderly patients with prominent negative symptoms 
(Harvey, Lombardi, Leibman, White, Parrella, Powchik, & Davidson, 1996). Despite 
the significant relationship between neurocognitive deficits and negative symptoms, 
negative symptoms are not merely secondary to neurocognitive deficits (Kirkpatrick, 
Fenton, Carpenter, & Marder, 2006). Studies have found that changes in cognition do 
not translate into changes in negative symptoms beyond the impact of antipsychotic 
treatment (Bark, Revheim, Huq, Khalderov, Ganz, & Medalia, 2003). Similarly, 
changes in negative symptoms do not lead to changes in neurocognitive deficits (Bell 
& Mishara, 2006; Hughes, Kumari, Soni, Das, Binneman, Drozd, et al., 2002). 
In addition to cognitive impairments, negative symptoms are associated with 
other indicators of neuropathology. Elevations in negative symptoms have been 
correlated with progressively enlarging ventricles (Garver, Nair, Christensen, 
Holcomb, Ramberg, & Kingsbury, 1992); however, further research has suggested 
that ventricular size is unstable and varies between periods of psychosis and 
remission (for a review, Garver, Holcomb, & Christensen, 2000). Negative symptoms 
have also been associated with reduced cerebral blood flow in the frontal lobes 
(Liddle, Friston, Frith, Hirsch, Jones, & Frackowiak, 1992) which may be related to 
neurocognitive dysfunction. Finally, it has been postulated that negative symptoms 
are associated with abnormal smooth pursuit eye movements (Ross, Thaker, 
Buchanan, Kirkpatrick, Lahti, Medoff, et al., 1997) and evidence has been found to 
support this (Ross, 2000). These studies indicate that there is a great deal of 
generalized brain dysfunction associated with negative symptoms in schizophrenia. 




are different from those associated with other aspects of schizophrenia provide some 
of the best evidence for different disease etiologies. Some studies have found that 
patients with a family history of schizophrenia were more likely to display elevated 
negative symptoms (Malaspina et al., 2000). More commonly, studies find that when 
patients with prominent negative symptoms have affected family members, these 
family members show a similar pattern elevated negative symptoms (Filbey, et al., 
1999; Garver, et al., 2000). Other studies have found that social withdrawal in 
relatives of patients with schizophrenia is a good predictor of negative 
symptomatology in the proband (Kirkpatrick, Ross, Walsh, Karkowski, & Kendler, 
2000). These studies suggest that negative symptoms can be, at least in part, inherited 
and that this heritability is distinct from that of other types of schizophrenic 
symptomatology. 
Section 4: Criticisms of the Current Conceptualization  
As can be garnered from the lines of research presented, negative symptoms 
are an important feature of the illness of schizophrenia. Additionally, evidence is 
available to support the concept of a categorically distinct subgroup of individuals 
with schizophrenia who show elevated levels of negative symptoms, as represented 
by the deficit syndrome. However, the concept of the deficit syndrome suffers from a 
major weakness, namely that is it based on arbitrary criteria. For instance, in the 
Schedule for the Deficit Syndrome (SDS; Kirkpatrick, Buchanan, Alphs, McKinney, 
and Carpenter, 1989) the first criteria required for a diagnosis of deficit schizophrenia 
is two or more negative symptoms; which, while based on clinical judgment, 




symptoms must have been expressed for at least the past year. The authors’ intention 
is to ensure that these symptoms are stable and trait-like; however, the time frame of 
twelve months is, again, purely arbitrary. Instead, it is important that criterion such as 
duration of illness or number of negative symptoms be identified empirically. 
In addition to the criteria of the deficit syndrome representing arbitrary 
cutoffs, there is also difficulty in the claim that the authors make about the categorical 
nature of this grouping of symptoms. The deficit syndrome is explicitly conceived of 
and assessed as categorical (Carpenter, at al., 1988). However, the observable 
structure of a phenomenon is dependent, in great part, on the tools which are used to 
measure it (Ruscio & Ruscio, 2004a). It is possible that the deficit syndrome criteria 
identify a group of individuals that receive extreme scores on the SDS. When 
compared to individuals that receive low scores, this group gives the appearance of 
being categorical. Such issues are not trivial and affect the way that disease models 
are tested (Haslam, 2003a). In order to reduce the heterogeneity of schizophrenia and 
uncover the divergent etiologies of the illness, valid subtypes of the illness must be 
identified. Using faulty divisions hampers our understanding of the illness and retards 
progress. Therefore, it is important to uncover true latent classes within the illness of 
schizophrenia in a systematic and scientific way. 
Taxometrics are a group of statistical techniques that allow for the quantitative 
determination of whether the underlying structure of a phenomenon is continuous or 
categorical (taxonic). These analyses were developed and advocated for by Paul 
Meehl (Meehl, 1995). They allow for the uncovering of statistical relationships 




1998). Taxometric methods have been shown to be superior to other forms of 
classification procedures (Waller & Meehl, 1998) and have been found to be more 
sensitive to taxonic results than other methods (Cleland, Rothschild, & Haslam, 
2000). 
These methods have been successfully used to investigate the taxonic nature 
of various psychopathologies. They have been applied to the investigation of 
narcissistic personality disorder (Foster & Campbell, 2007), borderline personality 
disorder (Clifton & Pilkonis, 2007), and antisocial personality disorder (Bucholz, 
Hesselbrock, Heath, Kramer, & Schuckit, 2000); as well as a variety of other 
personality disorders (Haslam, 2003b). These methods have also been applied to Axis 
I disorders such as depression (Baldwin & Shean, 2007) and anxiety (Bernstein, 
Zvolensky, Norton, Schmidt, Taylor, Forsyth, et al., 2007). Recently, they have also 
been applied to the investigation of negative symptoms. 
In a 2005 study, Blanchard, Horan, and Collins investigated the latent 
structure of negative symptoms within a group of 238 patients with a diagnosis of 
schizophrenia, schizoaffective disorder, or schizophreniform disorder. The authors 
predicted that approximately 25-30% of the patients with schizophrenia in this group 
would be classified in the negative symptom taxon, which is in line with previous 
predictions for the deficit syndrome (Kirkpatrick, et al., 2001). In addition, it was 
predicted that proportionately more males would be found within the taxonic group 
and that individuals in this group would evidence worse social functioning. These 
investigators found that there was a latent class, and that it represented about 28-36% 




likely to be male and exhibited worse psychosocial functioning; however, the two 
groups did not differ in terms of psychotic symptoms. 
Results from this study are encouraging, but as the authors note, there are 
several limitations that must be addressed. First, the sample size of 238 is small, and 
towards the lower end of what is recommended for these analyses. Typically, in order 
to conduct a latent class analysis, a sample size of at least 300 is recommended 
(Meehl, 1995). In addition, the nature of taxometric analysis requires replication 
before confidence can be had in the results (Waller & Meehl, 1998), something the 
authors readily acknowledge. In addition, the sample in this paper was 
nonrepresentative. 
Patients in this study were chronically ill and stable on antipsychotic 
medications. Other samples must be investigated to verify the generalizability of the 
sample. Finally, if the expectation is that the negative syndrome is due to biological 
underpinnings of the disease, then it should be demonstrable in an international study 
and not only evident in a single country. 
 




Chapter 3: Rationale for the Current Study 
The purpose of this study is to investigate the latent structure of negative 
symptoms in large representative sample of individuals with schizophrenia. The 
World Health Organization study, the Determinants of Outcome of Severe Mental 
Disorders was an extensive study of 1,379 patients seeking first-time treatment for 
severe mental illness in ten different countries. Data from this study will be subjected 
to taxometric methods in an attempt to examine the following hypotheses: 1) that a 
negative symptom taxon does exist; 2) that this subtype represents approximately 25- 
35% of the sample; 3) in agreement with the deficit syndrome, that patients in this 
taxon will have lower rates of depression and be more likely to be male; and 4) that 
there will be no difference in the severity of psychotic symptoms between patients in 









Chapter 4: Method 
Section 1: The WHO Ten-Country Study of Schizophrenia  
From 1978-1984, the World Health Organization began an extensive 
epidemiological study of schizophrenia. This study was known as the Determinants of 
Outcome of Severe Mental Disorders. The investigation took place at twelve different 
sites in ten different countries. Participants were recruited from India, Colombia, the 
United States, Denmark, Japan, the United Kingdom, Ireland, the Czech Republic, 
Nigeria, and Russia. After initial screening, 1,379 individuals were included in the 
study. Follow-ups were conducted at two and ten years after the beginning of the 
study. 
The objective of the study was to describe first-episode patients (or, at least 
patients who had never sought treatment before). Subjects were included in the study 
if they were between the ages of 15-54 years of age and had shown at least a) one 
definitive symptom of psychosis (i.e.-hallucinations, delusions, or bizarre behavior) 
or b) at least two symptoms that indicated probable psychosis (i.e.-significant social 
withdrawal). Participants were recruited from local area treatment centers (including 
local healers at some sites). Participants were excluded if there was evidence of 
organic brain dysfunction. Further, because this was a study of first episode patients, 
if the subject had ever previously sought treatment for the presenting complaint, they 
were not included in the study. 
Section 2: Measures 




psychiatrists or other qualified investigators (i.e.-a clinical psychologist or social 
worker). Tapes were exchanged between sites to ensure reliability and consistency 
(Jablensky, 1987). 
Current psychopathology was assessed using the 9th edition of the Present 
State Exam (PSE) (Wing, Cooper, & Sartorious, 1974). This is a semi-structured 
interview that is designed to be administered by a trained psychiatrist (Cooper, 
Copeland, Brown, Harris, & Gourlay, 1977). The reliability of this instrument is has 
been found to be acceptable (Wing, Nixon, & Mann, Leff, 1977; Luria, & McHugh, 
1974) , however it has been found to be reliant to a great degree on the training of the 
person administering the interview (Jablensky, 2002). For the WHO study, only 
trained psychiatrists were permitted to administer this interview. Again, reliability 
between interviewers was constantly assessed via reliability training and tape 
exchange between the sites (Jablensky, 1987). 
Section 3: Statistical Method 
Taxometric analysis is dependent upon the number of independent factors 
identified in the data; therefore, determination of the taxometric method to be used 
will be made after the number of independent factors in the WHO study have been 
identified. These factors will be identified via factor analysis. Likely candidates for 
this include: social withdrawal, blunted/flattened affect, and avolition. 
MAMBAC 
MAMBAC (mean above minus below a cut) only requires two factors. In this 
procedure one factor is used as an input variable and the other as the output. A cut is 




at or above this point is created. A mean is also calculated for the people who score 
below this cut. Differences between the means are plotted. Like MAXCOV, 
MAMBAC provides a base rate estimate for taxon members. 
The results are graphed. If the graph is U-shaped, this is an indication of a 
non-taxometric result. However, an inverted U-shaped graph represents a taxon. The 
idea being that a “bulge” or “peak” will result wherever there is a large difference 
between the two groups. If the bulges occur on the extreme ends of the graph 
(creating a U-shaped curve) then this means that there is a big difference between 
scores on either extreme of the curve and the rest of the group. However, if a true 
concave curve is found, then this is a taxon. It is expected that there will be a large 
difference between members of the taxon and people who are not in the taxon. (Using 
the example from before, people who score high on social withdrawal are expected to 
also score high on affective blunting.) 
MAXCOV 
Maximum covariance is a method that is designed to find the points of 
maximum correlation between at least three factors. One of the three factors will 
serve as an input variable. The covariance between this factor and the other factors 
are examined along their ranges. If a latent class exists, then the correlations will not 
be homogenous along the continuum of the anchor factor. Instead, a peak of 
maximum covariance will appear when there is an equal mix of the taxon and 
nontaxonic groups. When graphically represented, a clear peak will be visible. If no 
peak exists, then differences between the two groups are likely dimensional. 





Chapter 5:  Results 
Section 1: Factor Analysis  
 In order to determine the number of independent factors to be used in the 
taxometric analyses, items from the Present State Exam were first analyzed using 
factor analysis (Table 1). Items measuring negative symptoms were culled from the 
PSE. These items were then submitted to a principle-components analysis using 
oblim rotation which yielded an eigenvalue scree plot with two independent factors. 
 To examine the stability of this two-factor solution, split-halves comparability 
coefficients were computed for the factor scores (Everett & Entrekin, 1980). For this, 
the data set was randomly split into two groups (using the random split procedure in 
SPSS). Using the two-factor score coefficients from each matrix, factor scores were 
computed. The correlations between the two sets of factor scores were computed for 
the entire sample in order to examine the stability of this solution. Results indicated 






PSE Items Related to Negative Symptoms 
 
Item Number  Title    Description 
______________________________________________________________________________________________________ 
22   Recent loss of Interest  There is a definite recent diminution in the subject’s interests, either 
some interests have been dropped, or the intensity of interest has 
decreased. ‘Recent loss of interest’ means ‘within the present episode of 
illness.’ 
 
28   Social Withdrawal   In the less intense form of the symptom, the subject does not seek 
company but does not refuse it when offered. In the more intense form, 
the subject actively withdraws and refuses company even when it is 
offered. 
 
36   Subjective Anergia and  The subject feels that he has been slowed down in movement and/or has 
Retardation   been markedly lacking in energy, compared to his usual condition. The 
symptoms may have lasted since the onset of the episode of illness but it 
is rated only on the past month. 
 
54   Loss of Affect   The subject complains that he has lost the ability to feel and/or to 
express emotions. He can remember a time when he did have this 
capacity (though it might have been months or years ago) and is quite 
clear about losing it. The symptom may be associated with depression 
(particularly chronic depressive apathy) and other affects. 
 
108   Self Neglect   Consider subject’s degree of cleanliness, state of hair, make-up and 
clothes, whether shaven or not, etc. Only rate self-neglect if there is 
marked lack of attention to at least one of these aspects of personal 
appearance. 
 
110   Slowness and   The subject sits abnormally still or walks abnormally slowly or takes a 
Underactivity   long time to initiate movement. The symptom has to be fairly marked and 
unusual for the subject. 
 
128   Blunted Affect   This term includes flatness of affect, emotional indifference and apathy. 
Essentially, the symptom involves a diminution or emotional response. 
The subject’s face and voice are expressionless, he does not become 
involved with the interview or respond emotionally to changing topics of 
conversation, he seems indifferent when apparently distressing matters 
are discussed (whether or not delusional). There is a very limited range 
of emotional expression. 
 
130   Slowness of Speech   There are long pauses before the subject answers and each word follows 
very slowly after the one before. Often the subject stops answering 
altogether and has to be reminded before starting again. The interview 
may be impossible to complete because the subject is so slow and cannot 
be hurried. 
 
134   Restricted Quantity   The subject repeatedly fails to answer, questions have to be repeated, 
of Speech    answers are restricted to the minimum often one word, or telegrammatic 
style. 
__________________________________________________________________________________ 
Items which loaded onto factor 1 included self-neglect, slowness and 
underactivity, blunted affect, slow speech, and restricted quantity of speech. These 
items were interpreted to reflect behaviors which could be observed by the 
interviewer and are consistent with the symptoms of flat and blunted affect. Items 
with loaded onto factor 2 included loss of interest, subjective anergia and retardation, 




subjective experiences that had to be reported by the subject and are consistent with 
the symptoms of anhedonia and asociatly. 
Table 2 
Factor Loading of the PSE Negative Symptom Items 
_______________________________________________________________________________________________________ 
Item         Factor 1   Factor 2 
_______________________________________________________________________________________________________ 
 
Item 22-Slow speech            .84        .33 
Item 28-Slowness and underactivity          .71        .39 
Item 36-Restricted quantity of speech         .66         .21 
Item 54-Blunted affect          .39        .18 
Item 108-Self-neglect           .25      -.01 
Item 110-Loss of interest           .17        .69 
Item 128-Subjective anergia and retardation         .16        .62 
Item 130-Social withdrawal          .16         .52 
Item 134-Lost emotions          .22        .45 
_____________________________________________________________________ 
Subscales were then calculated from these factors. Items receiving 
eigenvalues of .30 or higher were summed on the respective factor. Self neglect only 
received a loading of .25, but was placed on factor 1 in order to increase the number 
of items. Internal consistency reliabilities (Cronbach's alphas) were calculated for 
each of the factors. The alpha score for factor 1 was .69 and for factor 2 the alpha was 
.66. 
Section 2: Mean Above Minus Below A Cut 
The taxometric procedure MAMBAC (mean above minus below a cut) only 
requires two input variables. For this procedure, one variable serves as an input 
variable and the other as the output variable. Cuts are made along the input variable 
and the means on the other variable are calculate above and below that cut. The 
difference is then taken between those two means and plotted. 
In order to conduct base rate analyses, a cut point was chosen to ensure that at 
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Figure 1: MAMBAC (mean above minus below a cut) curves for factors 1 and 2 
Plots from the MAMBAC analyses were consistent with a taxon (figure 1). 
Typically, dish-shaped plots are characteristic of taxonic results; however, up-ward 
sloping MAMBAC plots can also be indicative of taxa with low base-rates (Meehl & 
Yonce, 1994). Base rates for the taxon group were calculated using the method 
outlined by Meehl (Meehl & Yonce, 1994). This procedure yielded a base-rate of .13 
for Factor 1 and .15 for Factor 2, yielding an average base rate of .14 for the negative 




Section 3: Maximum Covariance 
The maximum covariance (MAXCOV; Meehl & Yonce, 1996) procedure 
requires at least three indicator variables. The factor analysis on the PSE conducted 
for this analysis only yielded two indicator variables. In order to corroborate the 
results from the MAMBAC analysis, a modified MAXCOV procedure was used 
(Gangestad & Snyder, 1985). These procedures have been used previously for 
taxometric analyses (Horan, Blanchard, Gangestad, & Kwapil, 2004; Korfine & 
Lenzenweger, 1995). In this procedure, two variables are chosen as the output 
variables. The other seven variables are combined into a summed scale and cuts are 
made along the range of the scale. Covariances of the two output variables are taken 
at each of these points. As with the MAMBAC analysis, cut points were chosen so 
that at least 20 individuals were present at points above and below those cuts. 
Covariance curves were calculated for each individual item and for the overall mean 
covariance curve. For these analyses, covariance curves for individual items were 
based on the median covariance of that item across all pairings with the eight other 
items selected from the PSE. The mean covariance curve was calculated by averaging 
across all of the 36 item pairings. 
As can be seen in figure 2, results from the MAXCOV analysis were each 
indicative of a taxon. Similar to the results obtained during the MAMBAC analysis, 
the graphs resulting from this analysis were upward sloping plots. Base rates for the 
latent class were calculated. For the MAXCOV procedure, the HITMAX interval is 
identified. In this interval is defined as the interval with the maximum amount of 
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Figure 2: MAXCOV (maximum covariance) curves for each item and for the mean across all pairings 
 
For individual items, base rates are calculated from an average of that item’s 
pairing with all other items (see Table 3). The overall base rate was calculated from 
the average of all 36 pairings. Results from this analysis yielded a base rate of .16. 
This base rate is comparable to the base rate calculated in the MAMBAC analysis, 





Base Rates Calculated for Individual Curves and for Average of the Curves 
_______________________________________________________________________________________________________ 
 
Item Content         Base Rate 
_______________________________________________________________________________________________________ 
 
Item 22-Slow speech              .13 
 
Item 28-Slowness and underactivity           .17 
 
Item 36-Restricted quantity of speech           .05 
 
Item 54-Blunted affect             .10 
 
Item 108-Self-neglect             .08 
 
Item 110-Loss of interest            .10 
 
Item 128-Subjective anergia and retardation          .10 
 
Item 130-Social withdrawal            .09 
 
Item 134-Lost emotions            .09 
 
Mean base rate             .16 
Section 4: Group Comparisons 
In order to compare the taxon to the non-taxon group, individuals had to be 
assigned membership basis of each individual’s scoring pattern on the nine indicator 
variables based on the MAXCOV analysis. Bayesian probabilities were calculated for 
each individual’s scoring pattern. Individuals who had a probability of .80 or greater 
of belonging to the taxon (N = 153) were assigned to the taxon group. All others were 
assigned to the compliment (nontaxonic) group (N = 539). 
In terms of demographic data, chi square tests revealed that the two groups 
were not significantly different on sex (x2 (1, N = 692) = .29, p = .60). The two 




       Age    Sex   Positive Symptoms   Depression 
_______________________________________________________________________________________________________ 
Group      (years)             Male        Female           (mean)       (mean) 
_______________________________________________________________________________________________________ 
Taxon      26.56               82              71                6.92         5.18** 
Compliment   27.87             302            237               6.40         2.67 
_______________________________________________________________________________________________________ 




In order to compare the taxon and non-taxon groups on symptomatology, 
items were culled from the PSE that related to positive symptoms (Table 6) and 
depression (Table 5). Items related to positive symptoms were combined into a 
summed scale. The two groups were not significantly different from one another in 
the severity of positive symptoms (t (307) = -.55, p = .15). Items related to depression 
were also combined into a summed scale and the two groups were compared to one 
another. It was found that individuals in the high probability taxon group had higher 
mean levels of depressive symptoms than individuals in the low probability taxon 
group (t (491) = -7.93, p < .00). 
Table 5 
PSE Items Related to Depression 
 
Item Number  Title    Description 
19   Inefficient Thinking   The subject complains that he is unable to think clearly or efficient or to 
reach decisions easily even about simple matters. His thoughts are 
muddled or slow and they tend to go round and round in aimless circles. 
 
20   Poor Concentration   The subject complains that he cannot give his full attention to matters 
which require it or not for as long as they require. At its most intense, 
the subject cannot even read a few sentences in a newspaper, cannot 
watch television and cannot take in a conversation. 
 
23   Depressed Mood   Depressed mood may be expressed in a number of ways – sadness, 
misery, low spirits, inability to enjoy anything, dejection. 
 
24   Hopelessness   The subject’s view of the future is bleak and without comfort. 
 
25   Suicidal Plans or Acts  Does not include a fleeting though about suicide; include a more 
deliberate consideration of planning and suicidal attempts that either 
were or were not intended to end in death. 
 
27   Morning Depression   The subject states unequivocally that depression is worst during the 
early part of the day and then improves. 
 
29   Self Deprecation   The subject feels inferior to others, even – in the most intensive form of 
the symptom – worthless. Do not rate delusions here. 
 
34   Loss of Weight   Rate only loss of weight due to poor appetite. 
 










PSE Items Related to Positive Symptoms 
__________________________________________________________________________________ 
Item Number  Title    Description 
 
43   Grandiose Ideas and   The subject feels that he is superbly healthy, has exceptionally high 
Actions    intelligence or extraordinary abilities. 
 
55   Thought Insertion   The essence of this symptom is that the subject experiences thoughts 
which are not his own intruding into his mind. The symptom is not that 
he has been caused to have unusual thoughts but that the thoughts 
themselves are not his. 
 
56   Thought Broadcasting  Distinguish it from thought reading. ‘Thought broadcasting’ is only 
or Thought Sharing   rated when the subject actually experiences his thoughts being shared 
with others. 
 
58   Thought Block or   The subject feels a sudden stopping of his thoughts, quite unexpectedly, 
Thought Withdrawal   while they are flowing freely, and in the absence of anxiety. 
 
59   Delusions of Thoughts  Subject feels that others can read his thoughts despite not sharing these 
Being Read   thoughts with others 
 
60   Non-verbal   This symptom includes noises, other than words, which have no real 
Hallucinations   origin in the world outside the subject but also no explicable origin in 
bodily processes, and which the subject regards as separate from his 
own mental processes. 
 
61   Affective or Non-   This symptom excludes non-verbal auditory hallucination. The most 
Specific Verbal   common form of the symptom is a voice calling the subject’s name or 
Hallucinations   simply saying one or two words only. 
 
62   Non-Affective Verbal  This symptom includes only a voice or voices heard by the subject 
Hallucinations (About  speaking about him and therefore referring to him in the third person. 
the Subject) 
 
63   Non-Affective Verbal  This symptom includes only a voice or voices heard by the subject 
Hallucinations (Spoken  speaking directly to him, and not depressive or grandiose in content or 
to the Subject)   mood 
 
64   ‘Dissociative’   The subject can hold a conversation (often two-way) with a presence 
Hallucinations   (variously described as a person, ghost, spirit, god, etc.) which may 
often be sensed in other ways, e.g., visually or by touch or smell. 
 
68   Olfactory Hallucinations  Simple olfactory hallucinations, such as a smell of orange peel or 
or Delusions   perfume,or a smell of ‘death’ or burning, which other people cannot 
smell. 
 
69   Delusion that Subject   If the subject thinks that he gives off a smell (though others cannot smell 
Smells    it 
 
70   Other Hallucinations and  If the subject has sensations other than auditory, visual, sexual, or 
Delusional Elaborations  olfactory 
 
71   Delusions of Control   The essence of the symptom is that the subject experiences his will as 
replaced by that of some other force or agency. 
 
72   Delusions of Reference  What is said by others may have a double meaning, or someone makes a 
gesture which the subject construes as a deliberate meaning. People 
may seem to be gossiping about the subject (beyond the bounds of 





73   Delusional Misinterpretations  Not only do people seem to refer to the subject directly but situations 
and Misidentifications  seem to be created which have special meaning. Things seem to be 
arranged to test him out, objects are arranged so that they have a 
special significance for him; this may go so far that whole armies of 
people may seem to be employed simply in order to discover what he is 
doing. 
 
75   Delusion of Assistance  The subject believes that someone, or some organization, or some force 
or power, is trying to help him. 
 
76   Delusions of Grandiose  The subject thinks he is chosen by some power, or by destiny, for a 
Ability    special mission or purpose, because of his unusual talents. 
 
77   Delusions of Grandiose  The subject believes he is famous, rich, titled or related to prominent 
Identity    people. 
 
78   Religious Delusions   Both a religious identification on the part of a subject (he is a saint or 
has special spiritual powers) and an explanation in religious terms of 
other abnormal experiences (e.g., auditory hallucinations) should be 
included. 
 
79   Delusional Explanations  Include here any delusional explanation or elaboration of other 
(Paranormal and Occult)  abnormal experiences, such as thought insertion or broadcast or 
delusions of reference or persecution, in terms of paranormal 
phenomena. 
 
80   Delusional Explanations  Include here any delusional explanations of other abnormal experiences 
(Physical)    such as thought insertion or broadcast or delusion of reference or 
persecution or somatic delusions, in terms of physical processes such as 
electricity, X-rays, television, radio, or machines of various kinds. 
 
81   Delusion of Alien Forces  This involves an external force which penetrates the subject’s mind or 
Penetrating or Controlling  body from outside – such as a ray which turns the liver to gold, alien 
Mind or Body   thoughts which pierce the skull or are injected into the mind, or a spirit 
which speaks with the subject’s voice, or a radio transmitter which has 
been implanted into the brain so that the subject’s thoughts are 
broadcast, etc. 
 
82   Primary Delusions   Primary delusions are based upon sensory experiences (delusional 
perceptions) in which a patient suddenly becomes convinced that a 
particular set of events has a special meaning. 
 
83   Subculturaly Influenced  Includes specific idiosyncratic beliefs held with conviction by small 
Delusions    subgroups within the community, e.g. sects, tribes or secret societies, but 
not by the community at large. 
 
85   Delusions of Pregnancy  The subject thinks she is pregnant although the circumstances make it 
clear that she cannot possibly be. 
 
86   Sexual Delusions and   Any delusion with a sexual content 
Hallucinations 
 
87   Delusions of Memories,  Delusional memories are experiences of past events which clearly did 
Confabulations, Fantastic  not occur but which the subject equally clearly remembers, e.g. ‘I came 
a delusion    down to earth on a silver star in 1964.’ 
 
88   Delusions of Guilt   The subject thinks he has brought ruin to his family by being in his 
present condition or that his symptoms are a punishment for not doing 
better. 
 
89   Simple Delusions   The subject has a strong feeling that something is wrong with his 
Concerning Apperance  appearance. 
 
90   Delusions of   The subject has a strong feeling as if he had no brain, a hollow within 
Depersonalizations   his skill, no thoughts in his head. 
 
91   Hypochondriacal Delusions  The subject feels that his body is unhealthy, rotten or diseased. 
 
92   Delusions of Catastrophe  The subject feels a sense of impending doom, that something awful will 




Section 5: Post Hoc Comparisons 
A previous taxometric analysis of a United States sample (Blanchard, et al., 
2005) did not find a relationship between depression and negative symptoms. This 
brings into question whether negative symptoms are independent of depression only 
in samples from the United States. 
To investigate the relationship between negative symptoms and depression in 
the current sample, levels of negative symptoms were first compared across study 
site. For these analyses, items from the PSE pertaining to negative symptoms were 
combined to create a summed scale. A one-way analysis of variance test revealed a 
significant main effect for study site on negative symptoms F (10, 681) = 5.612, p < 
.00. A test of homogeneity of variance was significant, so a Dunnett's T3 post-hoc 
comparison was used. It was found that the site from the United States (Honolulu) did 
significantly differ from two other sites (Aarthus, Denmark: F (10, 681) = 2.89, p < 
.00; Nottingham, England: F (10, 681) = 2.11, p = .04). Given that the US sample 
only significantly differed from two of the eleven sites, it cannot be said that the US 
sample was dramatically different from the overall sample. 
Next, the relationship between negative symptoms and depression was 
investigated across study sites. Pearson's product-moment correlations were 
calculated between the depression summed scale and the negative symptom summed 
scale across the different sites. Significant correlations (Table 7) were found in the 
Cali, Colombia sample (r (77) = .38, p < .00), the Moscow, Russia sample (r (19) = 
.72, p < .00), the Honolulu, USA sample (r (35) = .61, p < .00), the Prague, 




.35, p < .00), the Nagasaki, Japan sample (r (67) = .63, p < .00), the Nottingham, 
England sample (r (17) = .59, p < .00), and the Dublin, Ireland sample (r (45) = .52, p 
< .00). Non-significant correlations were found in the samples from Aarthus, 
Denmark (r (13) = .02, p = .95), Arga, India (r (4) = .33, p = .53), and Ibadan, Nigeria 
(r (16) = .34, p = .23). These results show that, on the whole, depression was related 
to negative symptoms in the sample as a whole. Additionally, the relationship 
between depression and negative symptoms that was observed in the entire sample 
was also significant in the sample from the United States. These findings, then, 
contradict those found in the Blanchard, et al. (2005) study. 
 
Table 7 
Correlation between depression and negative symptoms across sites 
 
Country        Aarthus        Arga        Cali        Ibadan        Moscow`        Hon.        Prague        Cah.        Nag.       Nott.      Dublin 
r .     02       .33     .38** `   .34               .72** ``         .61** `      .53** `       .35** `    .63**     .59**     .52** 
* p = .05; ** p < .01 
Next, correlations between the depression summed scale and individual 
negative symptom variables were calculated in order to further explore the nature of 
this relationship. First, the broad negative symptom factors were examined. 
Significant correlations were found between depression and factor 1 (r (491) = .13, p 
< .00), and factor 2 (r (491) = .58, p < .00). Given the large discrepancy between 
these two correlations, it was decided to test whether factor 2 was significantly more 
correlated with depression than factor 1. Using the procedure outlined by Meng, 
Rosenthal, and Rubin (equation 1; 1992) it was determined that the two correlations 
were significantly different (Z (693) = -9.86, p < .00), which indicates that factor 2 is 
more correlated with depression than factor 1. 




depression summed scale, individual negative symptoms were then entered into a 
Person's product-moment correlation with the depression summed scale. Significant 
correlations were found between depression and loss of interest (r (491) = .49, p < 
.00), social withdrawal (r (491) = .46, p < .00), subjective anergia and retardation (r 
(491) = .48, p < .00), lost emotions (r (491) = .33, p < .00), slowness and 
underactivity (r (491) = .23, p < .00), slow speech (r (491) = .17, p < .00), and 
restricted quantity of speech (r (491) = .09, p < .00). Nonsignificant correlations were 
found between depression and blunted affect (r (491) = -.05, p = .29) and self-neglect 
(r(491) r = .07, p = .12). 
Table 8 
Correlation between negative symptoms and depression: Individual items 
 
Depression SS x Negative Symptom SS 
 
Factor 1- Observed      .13** 
 
Self- Neglect     .07 
 
Slowness and Underactivity    .23** 
 
Blunted Affect     -.05 
 
Slow Speech     .17** 
 
Restricted Quantity of Speech    .09** 
 
Factor 2- Subjective      .58** 
 
Loss of Interest     .49** 
 
Subjective Anergia and Retardation   .48** 
 
Social Withdrawal     .46** 
 
Lost Emotions     .33** 
* p = .05; ** p < .01 
Next, because depression and positive symptoms have been found to be 
associated in other samples of individuals with schizophrenia, (Lindenmayer, 
Grochowski, & Kay, 1991; Sax, Strakowski, Keck, & Upadhyaya, 1996) a Pearson’s 
product-moment correlation was calculated using the positive symptom summed 




symptoms was not significant (r (461) = .11, p = .09). 
Finally, because of the well-known association between depression and sex 
(Nolen-Hoeksema, 1995), it was decided to check for a sex by group interaction. A 
univariate ANOVA revealed a nonsignificant sex by taxon interaction (F (1, 487) = 






Chapter 6:  Discussion  
The purpose of this study was to investigate the structure of negative 
symptoms in a large, representative sample of individuals with schizophrenia. It was 
hypothesized 1) that a negative symptom taxon would exist; 2) that this subtype 
would represent approximately 25-35% of the sample; 3) that individuals in the 
taxonic group would be more likely to be male, and have lower rates of depression; 
and finally, that there would be no difference in severity of psychotic symptoms 
between the two groups. 
This study replicated the results of Blanchard, et al. (2005). That study found 
that the structure of negative symptoms in a sample of patients with schizophrenia 
was taxonic. In the current study, taxometric analyses of the PSE resulted in evidence 
for a high negative symptom latent taxon across both MAMBAC and MAXCOV 
procedures. These results, in combination with the results of the Blanchard, et al. 
(2005) study provide support for the concept of a latent class of individuals with 
schizophrenia with a high level of negative symptoms. 
Base rates from these taxometric analyses ranged from .14 to .16. These 
estimates were consistent across both the MAMBAC and MAXCOV taxometric 
procedures. These base rates are lower than those estimated in a previous taxometric 
analysis (Blanchard, et al, 2005), which found an estimated base rate of .28-.36. In 
addition, these rates are lower than those of the deficit syndrome, which is generally 
estimated at approximately .30 (Kirkpatrick, et al., 2006). The base rate estimations in 
this study, however, have been reported in a study of the deficit syndrome in Spanish 




.32. In addition, previous research has found that early age of onset is not associated 
with the deficit syndrome (Kirkpatrick, Castle, Murray, & Carpenter, 2000) and that 
first-episode schizophrenia may be associated with lower rates of the deficit 
syndrome (Mayerhoff, Loebel, Alvir, & Szymanski, 1994). The low base rates found 
in this study, then, do not contradict previous findings. 
Prior research suggests that negative symptoms are not associated with 
depression, or positive symptoms, but are associated with the male sex. Comparisons 
were made in this sample between the taxon and compliment groups in order to 
determine the relationship between negative symptoms and these other variables. 
Comparisons of the two groups revealed that they did not differ in terms of age or 
sex. Previous research has not found an association between age and negative 
symptoms (Kirkpatrick and Buchanan, 1990); therefore, this finding was not 
unexpected. More surprising, however, was the finding that there were no significant 
sex differences between the two groups. The previous taxometric analysis by 
Blanchard, et al. (2005) study found that there were more males in the latent class 
taxon than females. Additionally, a meta-analysis of research on the deficit syndrome 
has found an association between deficit syndrome schizophrenia and the male sex 
(Roy, Maziade, Labbe, and Merette, 2001). At this time, sex differences in negative 
symptoms have not been sufficiently investigated in international samples. Given that 
the results from this study contradict previous findings, no firm conclusions can be 
drawn at this time. Further research is warranted. 
The high and low probability taxon groups also did not differ in terms of 




positive and negative symptoms to be largely independent of one another (Lewine, et 
al., 1983; Palacious-Arus, et al., 1995; & Nakaya, et al., 1999), so this finding was 
also expected. 
Perhaps the most surprising finding in this analysis was the strong association 
between depression and negative symptoms. When individuals from the high and low 
probability taxon groups were compared with one another, the mean level of 
depression was significantly higher in the high negative symptom taxon (t (491) = - 
9.61, p < .00). It was also found that negative symptoms were correlated with 
depression across some, but not all, of the research sites. 
In order to further investigate the relationship between negative symptoms and 
depression, Pearson’s product-moment correlations were calculated between each of 
the two factors and depression and each of the individual negative symptoms and 
depression. It was found that depression was significantly correlated with both factor 
1 and factor 2; however, it was also found that factor 2 had a significantly higher 
correlation with depression than did factor 1. Factor 1 was considered to be the 
subjective report of negative symptoms. This factor included items that could be 
considered to be more associated with depression than the factor 1 items, which was 
related to the observed manifestation of negative symptoms. 
The individual items were also found to be associated with depression. Loss 
of interest, social withdrawal, subjective anergia and retardation, lost emotions, 
slowness and under-activity, slow speech, and restricted quantity of speech were all 
found to be significantly correlated with the depression summed scale. The only two 




blunted affect and self-neglect. 
The findings from this investigation are difficult to interpret. Previous 
research has shown that negative symptoms can be reliably measured independent of 
depression in schizophrenia (Pouge-Geile & Harrow, 1984; Kuck, Zisook, 
Moranville, & Heaton, 1992; Kirkpatrick, Buchanan, Breier, & Carpenter, 1994; 
Malla, Takhar, Norman, Manchanda, Cortese, Haricharan, Verdi, Ahmed, 2002). The 
fact that the two constructs were so related in this sample causes one to question 
whether depression, rather than negative symptoms, was being captured in this study. 
Further complicating this analysis was the fact that positive symptoms and depression 
were independent of one another in this sample. Previous research has found a 
correlation between depression and positive symptoms (Lindenmayer, et al., 1991; 
Sax, et al., 1996). Further research is warranted to further investigate these 
relationships. 
Given the relationship between depression and negative symptoms in this 
sample, it was decided to examine the subscales in the PSE from which the items 
identified as negative symptoms came. Items from the PSE were divided up into a 
variety of syndromes by the authors of the measure. The syndrome associated with 
each negative symptom item was examined (Table 9). Only one of the items (item 54, 
lost affect) was considered to be a part of the “special features of depression” 
syndrome. Given that only one of these items came from a syndrome explicitly 
designed to assess depressive symptomatology, the high degree of correlation 
between the individual negative symptoms and depression does not appear to be 






PSE Syndrome Associated with Each Item 
 
Item Number  Description    Associated Syndrome 
 
22   Loss of Interest    Loss of Interest and Concentration 
 
28   Social Withdrawal   Social Unease 
 
36   Subjective Anergia   Lack of Energy 
 
54   Lost Affect    Special Features of Depression 
 
108   Self Neglect    Self-Neglect 
 
110   Slowness and Underactivity  Slowness 
 
128   Blunted Affect    Affective Flattening 
 
130   Slow Speech    Slowness 
 
134   Restricted Quantity of Speech  Slowness 
 
From the findings of this study, one might conclude that negative symptoms 
and depression are indistinguishable from one another in the schizophrenia 
population. This would be an inaccurate conclusion. As was mentioned previously, 
negative symptoms can be reliably measured independently of depression in 
schizophrenia (Pouge-Geile & Harrow, 1984; Kuck, et al., 1992; Malla, et al, 2002; 
Kirkpatrick, et al., 1994). Negative symptoms and depression have also been found to 
have be predictive of different outcomes (Roca, Bellino, Calvarese, Marchiaro, Patria, 
Rasetti, & Bogetto, 2005). In addition, some may question whether the fact that the 
results were taxonic implicitly indicates that the two are associated due to a similar 
biological etiology. This assumption would also be incorrect. Meehl (1999) noted that 
although genetic and biological reasons can cause latent classes, that “there is nothing 
about the etiological concept of a taxon, or about the mathematics of detecting one, 




finding that depression and negative symptoms were found to associated in this study 
do not necessarily cast doubt on the concept of negative symptoms as a construct 
independent of depression. 
A few limitations must be noted. First, as mentioned above, the conflation of 
negative symptoms and depression speaks to the lack of an instrument specific to 
negative symptoms. The development of measurements specific to negative 
symptoms did not occur until after this study had been completed. Conceptualizations 
of negative symptoms have been refined since when the PSE was developed. In 
particular, as noted above, the publication of Andreason’s SANS in 1983 marks an 
important milestone in this development. 
In this study, the PSE appears to conceptualize these items as being state-like, 
instead of trait-like. As noted above, in Carpenter’s conceptualization, negative 
symptoms should only count towards the diagnosis of the deficit syndrome if they are 
enduring, or trait-like (Carpenter, et al., 1988). While this study was not designed to 
be an explicit confirmation of the deficit syndrome, there is general agreement in the 
field that particular attention should be paid to enduring, trait-like negative symptoms 
in the study of schizophrenia (Kirkpatrick, et al., 2006). Had an instrument more 
suited for the identification of negative symptoms been employed, more confidence 
could have been had in the results. 
Given the importance of identifying trait-like and enduring negative 
symptoms, the question then becomes how best to measure these symptoms. A simple 
time-delimited cut-off such as the 1-year criterion mandated for the deficit syndrome 




year criterion appears to be largely divorced from empirical evidence and based 
mostly on clinical judgment. Alternatives to this approach, however, have not been 
forthcoming. In the absence of any empirical data for an appropriate time frame, the 
concept of persistent negative symptoms as outlined by Buchanan (2007) can provide 
some guidance for further development. This concept was posed as a relaxed 
alternative to the deficit syndrome for the purpose of clinical trials. In contrast to the 
deficit syndrome, secondary negative symptoms can be applied to the diagnosis of 
persistent negative symptoms, so long as they have been present for at least six 
months and so long as they have not been responsive to treatment. These relaxed 
criteria may prove to be easier to diagnose and capture a larger portion of the 
population than the deficit syndrome; however, more empirical data is needed before 
it can be applied to large-scale studies. 
Additional changes should be made to the PSE in order to improve its ability 
to capture negative symptoms. As previously mentioned, identifying whether the 
negative symptoms were primary and endogenous to the illness or secondary to other 
causes is of critical importance. In this study, it is unclear whether the symptoms that 
have been identified are actually negative symptoms, depression, or a mix of the two. 
Taking a cross-sectional measure of negative symptoms makes it difficult to assess 
whether an individual’s symptoms are primary or secondary unless there is a 
complete absence of any factor which negative symptoms can be secondary to. A 
long term assessment of the symptomatology is ideal in making this distinction. This 
is, however, not always possible or practical in a study of this magnitude. 




could make a judgment about whether the negative symptoms are primary or 
secondary. Again, this approach, while beneficial, could pose a logistical 
impossibility in a large, international study. Again, the approach outlined by 
Buchanan (2007) could pose a viable alternative. The criteria for persistent negative 
symptoms is more relaxed than those for the deficit syndrome and allows for the 
inclusion of secondary negative symptoms so long as they can be shown to be 
clinically relevant (see the criteria outlined previously). These criteria would still 
place a substantial burden on an investigator, however, the inclusion of secondary 
negative symptoms could allow for the inclusion of clinically relevant symptoms that 
cannot be definitively ruled as primary. 
Finally, consideration must be given to the emerging literature on the 
difficulties that individuals with schizophrenia appear to have in reporting anhedonic 
symptoms. For instance, Gard, Kring, Gard, Horan, and Green (2007) found that 
while individuals with schizophrenia could accurately report pleasure for events they 
had immediately experienced (consummatory pleasure) they showed deficits in 
reporting pleasure for events that were in the future (anticipatory pleasure). Similarly, 
Burbridge and Barch (2007) found that when viewing emotionally evocative pictures, 
individuals with schizophrenia showed no deficit in reporting their experienced 
pleasure. They did, however, show a deficit in reporting pleasure on a traditional 
measure of anhedonia in schizophrenia. This deficit was moderated by deficits in 
working memory. 
Individuals with schizophrenia may need substantial coaching in order to 




cognitive impairments that are a feature of this disorder can interfere with their ability 
to self-report. In the WHO study, the PSE did not allow for the in-depth questioning 
that may be necessary for individuals with schizophrenia to provide an accurate 
description. In a similar vein, current measures of negative symptoms (such as the 
SDS; Kirkpatrick, et al, 1989) do not provide extensive prompting, instead allowing 
for the subject to provide single word answers with little questioning. Any additional 
measure of negative symptoms needs to consider this point and provide ample 
opportunity and prompting for individuals with schizophrenia to report their 
experiences. 
In summary, the findings of this study do support the existence of a negative 
symptom taxon; however, this taxon group also evidenced high levels of depression. 
These findings contradict several previous studies that support the independence of 
negative symptoms and depression in individuals with schizophrenia. It is likely that 
the measurement used in this study, the PSE, was not well suited for the detection of 
negative symptoms as they are currently conceptualized. Future studies are warranted, 
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